Arcturus Therapeutics Holdings, Inc. (ARCT)
7.27
+0.17
(+2.39%)
USD |
NASDAQ |
Jan 21, 16:00
7.26
-0.01
(-0.14%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Research and Development Expense (TTM): 101.81M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | 55.38M |
| Perspective Therapeutics, Inc. | 61.22M |
| Novavax, Inc. | 369.02M |
| Sangamo Therapeutics, Inc. | 104.77M |
| Myomo, Inc. | 6.879M |